Follow
Lingling Zhu
Lingling Zhu
lung cancer center, west china hospital
Verified email at mgh.harvard.edu
Title
Cited by
Cited by
Year
MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway
LI Li, J Zhao, S Huang, Y Wang, L Zhu, Y Cao, J Xiong, J Deng
Gene 641, 240-247, 2018
592018
Sophoridine inhibits lung cancer cell growth and enhances cisplatin sensitivity through activation of the p53 and Hippo signaling pathways
L Zhu, S Huang, J Li, J Chen, Y Yao, L Li, H Guo, X Xiang, J Deng, ...
Gene 742, 144556, 2020
312020
The promising role of miR-296 in human cancer
L Zhu, H Deng, J Hu, S Huang, J Xiong, J Deng
Pathology-Research and Practice 214 (12), 1915-1922, 2018
262018
Significant association of YAP1 and HSPC111 proteins with poor prognosis in Chinese gastric cancer patients
S Huang, L Zhu, Y Cao, L Li, Y Xie, J Deng, J Xiong
Oncotarget 8 (46), 80303, 2017
182017
Prognostic significance of nuclear Yes-associated protein 1 in patients with nonsmall cell lung cancer: a systematic review and meta-analysis
L Zhu, G Ma, J Liu, Y Deng, Q Wu, W Chen, Q Zhou
Medicine 98 (16), e15069, 2019
122019
Molecular regulatory network of PD-1/PD-L1 in non-small cell lung cancer
The system can't perform the operation now. Try again later.
Articles 1–6